Published on
December 19, 2025
- 18:37 GMT
Akttyva Therapeutics Announces AIDE 2.0 Platform and Discovery of Novel Allosteric MK2 Modulator Classes
Akttyva Therapeutics files of a patent application covering AIDE 2.0, an early stage next-generation high-performance computational drug discovery platform WATERTOWN, MA, UNITED STATES, December 19, 2025 /EINPresswire.com/ -- Akttyva Therapeutics, Inc. …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
